Avinash Tiwari
Avinash Tiwari has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Duncan Khanikar
Department of Oncology, Assam Cancer Care Foundation (Dibrugarh Branch), Guwahati, India
6 shared publications - Altaf H. Shah
Professor and Head, Department of Gastroenterology, SKIMS, Srinagar, Jammu and Kashmir, India
3 shared publications - Jaswinder Singh Sodhi
Department of Gastroenterology, Sheri-I-Kashmir Institute of Medical Sciences, Srinagar, India
3 shared publications - Malay Sharma
Department of Gastroenterology, Aryavart Hospital, Meerut, India
3 shared publications - Sandeep Kumar Prajapati
CSIR-National Geophysical Research Institute 1 , Hyderabad - 500 007
3 shared publications - Shaheena Parveen
Department of Medical Gastroenterology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, India
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (5) , 806-820
Development and preliminary evaluation of a novel low-cost endoscopic retrograde cholangiopancreatography simulator with electrocautery training capability: a proof-of-concept study from India
Background/Aims: Endoscopic retrograde cholangiopancreatography (ERCP) requires extensive training, with around 350–400 supervised cases being required for proficiency. Existing simulators face costs, limited availability, and limited realism. Therefore, we developed and preliminarily evaluated a minimal ERCP training model that incorporated electrocautery capabilities.Methods: A five-phase development process was employed, including needs assessment, iterative prototyping with material optimization, technical performance testing across 50 training sessions, comparative analysis against existing simulators, and preliminary expert evaluation by eight experienced endoscopists (mean ERCP experience: 12.3±4.2 years). The primary outcomes included verification of functional capability, cost analysis, durability assessment, and expert ratings on 5-point Likert scales for realism and educational value.Results: The simulator successfully achieved biliary cannulation in 48/50 sessions (96.0%), supported needle knife precut training with functional electrocautery, and demonstrated compatibility with C-arm fluoroscopy, providing adequate contrast visualization. The total material cost per unit was 47.32 United States dollars (USD), compared to 180,000–250,000 USD for commercial virtual reality simulators. The model withstood 50 sessions without structural failure (onion bulb replacement was required every 8.2±1.4 precut attempts). Expert ratings indicated high scores for anatomical realism (4.1±0.6), tactile feedback (3.9±0.7), and educational value (4.4±0.5).Conclusions: This novel, low-cost ERCP simulator demonstrated technical feasibility and face validity. This proof-of-concept requires formal prospective validation studies to establish construct validity, concurrent validity, and educational effectiveness through trainee learning outcomes before conclusions regarding the impact on clinical training can be drawn. The innovation addresses significant accessibility barriers but represents preliminary evidence that requires formal educational validation.
- 30 September 2026
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 59 (5) , 806-820
Open AccessDevelopment and preliminary evaluation of a novel low-cost endoscopic retrograde cholangiopancreatography simulator with electrocautery training capability: a proof-of-concept study from India
Background/Aims: Endoscopic retrograde cholangiopancreatography (ERCP) requires extensive training, with around 350–400 supervised cases being required for proficiency. Existing simulators face costs, limited availability, and limited realism. Therefore, we developed and preliminarily evaluated a minimal ERCP training model that incorporated electrocautery capabilities.Methods: A five-phase development process was employed, including needs assessment, iterative prototyping with material optimization, technical performance testing across 50 training sessions, comparative analysis against existing simulators, and preliminary expert evaluation by eight experienced endoscopists (mean ERCP experience: 12.3±4.2 years). The primary outcomes included verification of functional capability, cost analysis, durability assessment, and expert ratings on 5-point Likert scales for realism and educational value.Results: The simulator successfully achieved biliary cannulation in 48/50 sessions (96.0%), supported needle knife precut training with functional electrocautery, and demonstrated compatibility with C-arm fluoroscopy, providing adequate contrast visualization. The total material cost per unit was 47.32 United States dollars (USD), compared to 180,000–250,000 USD for commercial virtual reality simulators. The model withstood 50 sessions without structural failure (onion bulb replacement was required every 8.2±1.4 precut attempts). Expert ratings indicated high scores for anatomical realism (4.1±0.6), tactile feedback (3.9±0.7), and educational value (4.4±0.5).Conclusions: This novel, low-cost ERCP simulator demonstrated technical feasibility and face validity. This proof-of-concept requires formal prospective validation studies to establish construct validity, concurrent validity, and educational effectiveness through trainee learning outcomes before conclusions regarding the impact on clinical training can be drawn. The innovation addresses significant accessibility barriers but represents preliminary evidence that requires formal educational validation.
- 22 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (02) , 217
Clinical and methodological considerations in artificial intelligence-assisted endoscopic ultrasonography for pancreatic mass detection
10.1055/a-2701-6530 I read with interest the recent article on the prospective clinical validation of the PANCRAIEUS artificial intelligence (AI) system for real-time detection of solid pancreatic masses during endoscopic ultrasonography (EUS) [1]. While the study marks an important advance toward integrating AI into pancreatic imaging, several methodological and clinical limitations merit consideration. The study does not address the critical distinction between exophytic pancreatic tumors and lesions arising from adjacent organs, such as gallbladder cancer infiltrating the pancreas. This differentiation is essential, as management strategies, surgical eligibility, and prognosis differ markedly between primary pancreatic neoplasms and secondary involvement. Without explicit evaluation of this boundary, detection rates may overestimate true pancreatic lesion identification [2]. Contrast-enhanced EUS is pivotal in characterizing pancreatic masses, enabling assessment of vascularity, necrosis, and enhancement patterns that aid in distinguishing adenocarcinoma from neuroendocrine tumors or inflammatory lesions [3]. The omission of contrast-enhanced EUS data limits applicability to real-world workflows, where multimodal EUS – including contrast enhancement – is increasingly standard practice. Beyond detection, EUS plays a central role in staging and surgical planning by evaluating vascular involvement (portal vein, superior mesenteric vessels, celiac axis) and regional lymphadenopathy [4]. The study does not report these parameters, narrowing the utility of the AI system to detection alone, without addressing its potential contribution to comprehensive staging. The discriminative architecture of the AI system is inherently prone to false positives when encountering atypical anatomy or artifacts [5]. The manuscript does not clarify whether safeguards such as uncertainty quantification, confidence thresholds, or secondary verification loops are incorporated to mitigate misclassification risk, particularly for less experienced operators. While the study demonstrates promising detection rates, the absence of lesion origin differentiation, contrast-enhanced EUS integration, resectability assessment, and defined error-handling mechanisms limits immediate clinical translation. Future work should incorporate these elements to ensure AI-assisted EUS evolves into a comprehensive, reliable tool for pancreatic disease evaluation. Article published online: 22 January 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 22 January 2026
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 58 (02) , 217
Clinical and methodological considerations in artificial intelligence-assisted endoscopic ultrasonography for pancreatic mass detection
10.1055/a-2701-6530 I read with interest the recent article on the prospective clinical validation of the PANCRAIEUS artificial intelligence (AI) system for real-time detection of solid pancreatic masses during endoscopic ultrasonography (EUS) [1]. While the study marks an important advance toward integrating AI into pancreatic imaging, several methodological and clinical limitations merit consideration. The study does not address the critical distinction between exophytic pancreatic tumors and lesions arising from adjacent organs, such as gallbladder cancer infiltrating the pancreas. This differentiation is essential, as management strategies, surgical eligibility, and prognosis differ markedly between primary pancreatic neoplasms and secondary involvement. Without explicit evaluation of this boundary, detection rates may overestimate true pancreatic lesion identification [2]. Contrast-enhanced EUS is pivotal in characterizing pancreatic masses, enabling assessment of vascularity, necrosis, and enhancement patterns that aid in distinguishing adenocarcinoma from neuroendocrine tumors or inflammatory lesions [3]. The omission of contrast-enhanced EUS data limits applicability to real-world workflows, where multimodal EUS – including contrast enhancement – is increasingly standard practice. Beyond detection, EUS plays a central role in staging and surgical planning by evaluating vascular involvement (portal vein, superior mesenteric vessels, celiac axis) and regional lymphadenopathy [4]. The study does not report these parameters, narrowing the utility of the AI system to detection alone, without addressing its potential contribution to comprehensive staging. The discriminative architecture of the AI system is inherently prone to false positives when encountering atypical anatomy or artifacts [5]. The manuscript does not clarify whether safeguards such as uncertainty quantification, confidence thresholds, or secondary verification loops are incorporated to mitigate misclassification risk, particularly for less experienced operators. While the study demonstrates promising detection rates, the absence of lesion origin differentiation, contrast-enhanced EUS integration, resectability assessment, and defined error-handling mechanisms limits immediate clinical translation. Future work should incorporate these elements to ensure AI-assisted EUS evolves into a comprehensive, reliable tool for pancreatic disease evaluation. Article published online: 22 January 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 December 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (1)
Beyond Detection: AI in Gastric Endoscopy
- 14 December 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (1)
Beyond Detection: AI in Gastric Endoscopy
- 10 November 2025
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 60 (6) , 564-566
“Navigating Antimicrobial Resistance and Reinfection in H. pylori: Therapeutic Strategies”
- 10 November 2025
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 60 (6) , 564-566
“Navigating Antimicrobial Resistance and Reinfection in H. pylori: Therapeutic Strategies”
- 7 November 2025
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 40 (12) , 3063-3064
Small SELs, Big Gains: Integrating On‐Site Stereomicroscopy With Advanced EUS Techniques for < 20 mm Lesions
- 7 November 2025
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 40 (12) , 3063-3064
Small SELs, Big Gains: Integrating On‐Site Stereomicroscopy With Advanced EUS Techniques for < 20 mm Lesions
- 30 October 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 103 (2) , 384-385
Stacking the odds: challenging the hierarchy in pancreas divisum detection
- 30 October 2025
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 103 (2) , 384-385
Stacking the odds: challenging the hierarchy in pancreas divisum detection
- 11 October 2025
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 28 (1)
Insight: How Time, Team, and Technique Shape Fistulotomy Safety and Efficacy
- 11 October 2025
- Published by Elsevier in Techniques and Innovations in Gastrointestinal Endoscopy
- Vol. 28 (1)
Insight: How Time, Team, and Technique Shape Fistulotomy Safety and Efficacy
- 22 October 2024
- Published by Elsevier in Gastroenterology
- Vol. 168 (2) , 425-426
CHRONICLE Trial: How Cool Is Cold Snaring for Endoscopic Mucosal Resection?
- 22 October 2024
- Published by Elsevier in Gastroenterology
- Vol. 168 (2) , 425-426
CHRONICLE Trial: How Cool Is Cold Snaring for Endoscopic Mucosal Resection?
- 10 July 2024
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 51 (4) , 687-688
An approach for EUS-guided FNAB for suspected gallbladder malignancy
- 10 July 2024
- Published by Springer Nature in Journal of Medical Ultrasonics
- Vol. 51 (4) , 687-688
An approach for EUS-guided FNAB for suspected gallbladder malignancy